Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    Open Studies | "Influenza in Birds"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Influenza in Birds"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting A Safety and Immunogenicity Study of IVACFLU-A/H5N1
Condition: Avian Influenza
Interventions: Biological: A/H5N1 vaccine;   Biological: Placebo Comparator
2 Not yet recruiting Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine.
Conditions: Avian Influenza;   H1N1 Influenza;   Influenza
Interventions: Drug: AS03;   Biological: Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203;   Biological: Monovalent influenza A/H7N9 virus vaccine
3 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Drug: MF59;   Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
4 Recruiting Safety and Immunogenicity of IVACFLU-A/H5N1 in Vietnamese Adult
Condition: Influenza A/H5N1
Interventions: Biological: IVAC-H5N1-15ug;   Biological: IVAC-H5N1-30ug;   Biological: IVAC-placebo
5 Recruiting Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Condition: A/Vietnam/H5N1 Influenza Virus
Interventions: Biological: 7.5 mcg H5N1 (stored as monobulk);   Biological: 15 mcg H5N1 (stored as monobulk);   Biological: 90 mcg H5N1 (stored as monobulk);   Biological: 90 mcg H5N1 (stored in vials);   Other: MF59;   Other: MF59 (stored as monobulk)
6 Recruiting H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
Conditions: Avian Influenza;   Influenza
Interventions: Drug: AS03;   Drug: MF59;   Biological: Monovalent Influenza A/H5N8 vaccine
7 Recruiting Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome (ARDS);   Multiple Organ Failure
Intervention: Drug: Menstrual blood stem cells
8 Recruiting Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults
Conditions: Influenza;   Healthy
Interventions: Biological: Multimeric 001 (M-001);   Biological: H5N1 influenza vaccine;   Biological: Saline
9 Unknown  Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
Condition: Pandemic Influenza
Intervention: Biological: Pandemic Influenza Vaccine (H5N1)
10 Recruiting A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults
Condition: Influenza
Interventions: Biological: recombinant influenza hemagglutinin;   Biological: Advax1;   Biological: Advax2
11 Recruiting A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Condition: Influenza
Intervention: Biological: Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).

Indicates status has not been verified in more than two years